摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-{5-[2-(4-fluorophenyl)oxazol-4-ylmethoxymethyl]-1,3-dioxan-5-ylmethoxymethyl}-6-methylbenzoate | 501362-24-9

中文名称
——
中文别名
——
英文名称
methyl 2-{5-[2-(4-fluorophenyl)oxazol-4-ylmethoxymethyl]-1,3-dioxan-5-ylmethoxymethyl}-6-methylbenzoate
英文别名
Methyl 2-[[5-[[2-(4-fluorophenyl)-1,3-oxazol-4-yl]methoxymethyl]-1,3-dioxan-5-yl]methoxymethyl]-6-methylbenzoate
methyl 2-{5-[2-(4-fluorophenyl)oxazol-4-ylmethoxymethyl]-1,3-dioxan-5-ylmethoxymethyl}-6-methylbenzoate化学式
CAS
501362-24-9
化学式
C26H28FNO7
mdl
——
分子量
485.509
InChiKey
RCQIARGXQQBFJV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    35
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    89.2
  • 氢给体数:
    0
  • 氢受体数:
    9

文献信息

  • Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
    申请人:——
    公开号:US20040122069A1
    公开(公告)日:2004-06-24
    Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, 1 in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.
    披露了二芳基环烷基衍生物及其生理上可接受的盐和生理功能衍生物。这些化合物包括式I,1中定义的基团,以及它们的生理上可接受的盐和制备方法。这些化合物通常具有降脂和/或三酸甘油酯降低作用,并且适用于例如治疗脂质代谢紊乱、II型糖尿病和X综合征等疾病。
  • Diarylcycloalkyl derivatives, processes for their preparation and their use s pharmaceuticals
    申请人:——
    公开号:US20030144332A1
    公开(公告)日:2003-07-31
    Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, 1 in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.
    披萨店的员工们正在忙着准备今晚的外卖订单。
  • US6624185B2
    申请人:——
    公开号:US6624185B2
    公开(公告)日:2003-09-23
  • US6884812B2
    申请人:——
    公开号:US6884812B2
    公开(公告)日:2005-04-26
  • US7399777B2
    申请人:——
    公开号:US7399777B2
    公开(公告)日:2008-07-15
查看更多